Poging GOUD - Vrij

Brazil Gives Nod to OneSource's Unit

Mint New Delhi

|

April 11, 2025

OneSource Specialty Pharma on Thursday said its flagship unit has received approval from the Brazilian health authority ANVISA (Agência Nacional de Vigilância Sanitária).

The company's Unit 2 facility in Bengaluru has been granted Good Manufacturing Practices (GMP) certification by ANVISA, the Brazilian health regulatory agency, following a suc

MEER VERHALEN VAN Mint New Delhi

Mint New Delhi

Mint New Delhi

How high credit card utilization affects your score: a quick guide

I had a ₹1 lakh credit card bill but repaid ₹40,000; ₹60.000 is due. Will it hurt my credit score? Can I take a personal loan to clear it? Will it affect my score and future loan applications? - Name withheld on request

time to read

1 mins

November 20, 2025

Mint New Delhi

Incentives drive each and every participant in all capital markets

Investors must note that everyone is motivated by self-interest whether we know the specifics or not

time to read

4 mins

November 20, 2025

Mint New Delhi

India's financial boom: Let's keep progress real

Record funds raised for shareholder exits rather than fresh investment go against the spirit of IPOs. The bigger issue is that the financial world must stay in sync with the real economy

time to read

2 mins

November 20, 2025

Mint New Delhi

Meta's big court win

Social media major Meta has won big relief as a US judge ruled in its favour in an antitrust case filed by the US Federal Trade Commission (FTC) that could have forced it to spin off Instagram and WhatsApp.

time to read

1 min

November 20, 2025

Mint New Delhi

xAI in talks to raise $15 billion in fresh equity

Elon Musk's artificial-intelligence startup xAI is in advanced talks to raise $15 billion in fresh equity at a valuation of $230 billion, The Wall Street Journal reported on Tuesday.

time to read

1 min

November 20, 2025

Mint New Delhi

Mint New Delhi

AYURVEDIC HOSPITAL CARE: WHY INSURERS PUSH BACK—AND HOW TO WIN CLAIMS

Over the past few years, a friend has undergone Ayurvedic treatment for fluctuating blood pressure at a Kerala hospital. The insurer had routinely covered a week of hospitalization, but this time rejected the claim, arguing the annual treatment appeared more like rest than medical necessity. Ayurvedic claims are becoming harder to get approved.

time to read

3 mins

November 20, 2025

Mint New Delhi

Fabindia-Biome row now in arbitration

The founders of personal care company Biome Life Sciences India Pvt. Ltd on Wednesday told the Delhi high court that they were withdrawing their petition against parent Fabindia Ltd over share valuations.

time to read

2 mins

November 20, 2025

Mint New Delhi

Mint New Delhi

A fresh perspective on abstraction in art

A new exhibition in Mumbai showcases different approaches to abstraction by artists like Zarina, Seher Shah and Mehlli Gobhai

time to read

3 mins

November 20, 2025

Mint New Delhi

Mint New Delhi

In a new avatar, Zomato steps into India's top 25 brands

Its brand value jumped 69% year-on-year, Kantar’s BrandZ report for 2025 shows

time to read

1 mins

November 20, 2025

Mint New Delhi

Bank-funded acquisitions won’t displace private credit

The Reserve Bank of India's (RBI) draft framework for bank-led acquisition finance marks a decisive policy turn: Indian banks can now enter the acquisition finance market within a clear perimeter, reshaping the competitive dynamics between banks and private credit funds.

time to read

3 mins

November 20, 2025

Listen

Translate

Share

-
+

Change font size